During the last session, CERo Therapeutics Holdings Inc. (NASDAQ:CERO)’s traded shares were 1.09 million, with the beta value of the company hitting -0.41. The 52-week high for the CERO share is $12.80, that puts it down -15900.0 from that peak though still a striking 12.5% gain since the share price plummeted to a 52-week low of $0.07. The company’s market capitalization is $4.16M, and the average intraday trading volume over the past 10 days was 1.7 million shares, and the average trade volume was 5.07 million shares over the past three months.
CERo Therapeutics Holdings Inc. (NASDAQ:CERO) trade information
CERo Therapeutics Holdings Inc. (CERO) registered a -4.03% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.03% in intraday trading to $0.08, hitting a weekly high. The stock’s 5-day price performance is -12.53%, and it has moved by -41.05% in 30 days. Based on these gigs, the overall price performance for the year is -99.26%. The short interest in CERo Therapeutics Holdings Inc. (NASDAQ:CERO) is 0.65 million shares and it means that shorts have 0.23 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CERO Dividends
CERo Therapeutics Holdings Inc. is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
